NCT03621670: Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

Sponsor: GlaxoSmithKline. Phase: PHASE3. Conditions: Infections, Meningococcal